Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei from Thailand

Aíto García Reneses · International Journal of Antimicrobial Agents · 2015

Summary

A re-evaluation of SXT resistance in Thailand found that this original collection of B. pseudomallei isolated from patients presenting to the same hospital between 1992 and 2003 was considerably lower than that reported by us previously.

Type: article
Published: 2015-05-01
Cited by: 32
References: 12
Access: Open access
DOI: https://doi.org/10.1016/j.ijantimicag.2015.01.006
PubMed: https://pubmed.ncbi.nlm.nih.gov/25758020/
PMC: https://www.ncbi.nlm.nih.gov/pmc/articles/4537509/
OpenAlex: https://openalex.org/W25758020
Semantic Scholar: https://api.semanticscholar.org/CorpusID:13501464

Keywords

Humanities, Philosophy

References

Carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii in the nosocomial setting in Latin America暁子藤原 — 2014
Performance standards for antimicrobial susceptibility testingMary Jane Ferraro — 2001
Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guidelineJames H. Jorgensen, Clinical — 2006
Comparative Review of the CarbapenemsGeorge G. Zhanel, Ryan Wiebe, Leanne Dilay — 2012
Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomalleiDavid A. B. Dance, Viengmon Davong, Sona Soeng — 2014
Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trialPloenchan Chetchotisakd, Wirongrong Chierakul, Wipada Chaowagul — 2014
Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei.Vanaporn Wuthiekanun, Allen Cheng, Wirongrong Chierakul — 2005
Characterization of carbapenem-resistant Pseudomonas aeruginosa clinical isolates, carrying multiple genes coding for this antibiotic resistanceCamila Rizek, Liang Fu, Leticia Cavalcanti dos Santos — 2014
Prevalence and genotypic relatedness of carbapenem resistance among multidrug-resistant P. aeruginosa in tertiary hospitals across ThailandPiyatip Khuntayaporn, Preecha Montakantikul, Piroon Mootsikapun — 2012
Medical progress: MelioidosisW. Joost Wiersinga, Bart J. Currie, Sharon J. Peacock — 2012

Cited by

The BpeEF-OprC Efflux Pump Is Responsible for Widespread Trimethoprim Resistance in Clinical and Environmental Burkholderia pseudomallei IsolatesNicole L. Podnecky, Vanaporn Wuthiekanun, Sharon J. Peacock — 2013
Burkholderia pseudomallei: primeiro caso de melioidose em PortugalAna Pelerito, Alexandra Nunes, Susana Coelho — 2015
Burkholderia pseudomallei: First case of melioidosis in PortugalAna Pelerito, Alexandra Nunes, Susana Carvalho Coelho — 2016
Burkholderia pseudomallei: Challenges for the Clinical Microbiology LaboratoryPeera Hemarajata, Jonathan Baghdadi, Risa M. Hoffman — 2016
Antibiotic Resistance Markers in Burkholderia pseudomallei Strain Bp1651 Identified by Genome Sequence AnalysisJulia V. Bugrysheva, David Sue, Jay E. Gee — 2017
Susceptibility of Clinical Isolates of Burkholderia pseudomallei to a Lipid A Biosynthesis InhibitorSineenart Sengyee, Natnaree Saiprom, Suporn Paksanont — 2017
Epidemiological cut-off value of clinical isolates of Burkholderia pseudomallei from Northern Queensland to meropenem, ceftazidime, trimethoprim/sulfamethoxazole and doxycycline by the microbroth dilution method.Samuel Maloney, Cathy Engler, Robert Norton — 2017
Burkholderia pseudomallei Isolates Resistance in Clinical and Environmental Responsible for Widespread Trimethoprim The BpeEF-OprC Efflux Pump IsHerbert P. Schweizer, Nicole L. Podnecky, Jacqueline Sharon — 2014
Mechanisms of Resistance to Folate Pathway Inhibitors in Burkholderia pseudomallei: Deviation from the NormNicole L. Podnecky, Katherine A. Rhodes, Takehiko Mima — 2017
Melioidosis in lower provincial Cambodia: A case series from a prospective study of sepsis in Takeo ProvinceKevin L. Schully, Catherine M Berjohn, Angela M. Prouty — 2017
Case Report: Chorioamnionitis and Premature Delivery due to Burkholderia pseudomallei Infection in Pregnancy.Michelle Porter, Craig E. Pennell, Patricia Woods — 2018
The relationship between bacterial sources and genotype to the antimicrobial resistance pattern of Burkholderia pseudomalleiMuhammad Abubakar Sadiq, Latiffah Hassan, Saleha Abdul Aziz — 2018
Pan-drug-resistant and biofilm-producing strain of Burkholderia pseudomallei: first report of melioidosis from a diabetic patient in Yogyakarta, Indonesia [Letter]David A. B. Dance, Vanaporn Wuthiekanun, Derek S. Sarovich — 2019
Antibiotics susceptibility of Burkholderia species of Sarawak originLua Viana Pangau, F. V. Sylvester, Yuwana Podin — 2018
Correlation Between Etest and Reference Broth Microdilution for Antimicrobial Susceptibility Testing of Burkholderia pseudomalleiDavid Lonsway, Mindy G. Elrod, Nathan Kendrick — 2020
Emerging Role of Biologics for the Treatment of Melioidosis and GlandersDaniel Tapia, Javier I. Sanchez-Villamil, Alfredo G. Torres — 2019
Burkholderia pseudomallei multi-centre study to establish EUCAST MIC and zone diameter distributions and epidemiological cut-off (ECOFF) values.Onur Karatuna, David A. B. Dance, Erika Matuschek — 2020
A Comparison Between 12 Versus 20 Weeks of Trimethoprim-sulfamethoxazole as Oral Eradication Treatment for Melioidosis: An Open-label, Pragmatic, Multicenter, Non-inferiority, Randomized Controlled TrialSiriluck Anunnatsiri, Wipada Chaowagul, Prapit Teparrukkul — 2020
Antimicrobial Susceptibility of Western Hemisphere Isolates of Burkholderia pseudomallei: Phenotypic and Genomic AnalysesJulia V. Bugrysheva, Christine Lascols, Heather P. McLaughlin — 2021
Genomic and RT-qPCR analysis of trimethoprim-sulfamethoxazole and meropenem resistance in Burkholderia pseudomallei clinical isolatesMarine Schnetterle, Olivier Gorgé, Flora Nolent — 2021

Related papers

No related papers recorded.